Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aliskiren and Valsartan in Proteinuric Kidney Disease
NCT01129557Phase 4Terminated
- Sponsor
- Columbia University
- Start
- Sep 2009
- Primary completion
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of aliskiren in proteinuric kidney disease, diabetic nephropathy (DN), hypertensive nephrosclerosis (HN), IgA nephropathy (IgAN), focal segmental glomerulosclerosis (FSGS), sponsored by Columbia University. Started Sep 2009; status: terminated.
02
Drugs
aliskiren
03
Conditions
proteinuric kidney diseasediabetic nephropathy (DN)hypertensive nephrosclerosis (HN)IgA nephropathy (IgAN)focal segmental glomerulosclerosis (FSGS)
Beyond the preview
Go deeper on NCT01129557.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01129557.